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ttp://dx.doi.org/10.1016/j.ajpath.2016.03.017The Bcl2-associated anthanogene (BAG) 3 protein is a member of the BAG family of cochaperones,
which supports multiple critical cellular processes, including critical structural roles supporting desmin
and interactions with heat shock proteins and ubiquitin ligases intimately involved in protein quality
control. The missense mutation P209L in exon 3 results in a primarily cardiac phenotype leading to
skeletal muscle and cardiac complications. At least 10 other Bag3 mutations have been reported, nine
resulting in a dilated cardiomyopathy for which no specific therapy is available. We generated aMHC-
human Bag3 P209L transgenic mice and characterized the progressive cardiac phenotype in vivo to
investigate its utility in modeling human disease, understand the underlying molecular mechanisms,
and identify potential therapeutic targets. We identified a progressive heart failure by echocardiography
and Doppler analysis and the presence of pre-amyloid oligomers at 1 year. Paralleling the pathogenesis
of neurodegenerative diseases (eg, Parkinson disease), pre-amyloid oligomerseassociated alterations
in cardiac mitochondrial dynamics, haploinsufficiency of wild-type BAG3, and activation of p38
signaling were identified. Unexpectedly, increased numbers of activated cardiac fibroblasts were
identified in Bag3 P209L Tgþ hearts without increased fibrosis. Together, these findings point to a
previously undescribed therapeutic target that may have application to mutation-induced myofibrillar
myopathies as well as other common causes of heart failure that commonly harbor misfolded proteins.
(Am J Pathol 2016, 186: 1989e2007; http://dx.doi.org/10.1016/j.ajpath.2016.03.017)Supported by the Jefferson-Pilot Corporation Fellowship in Academic
Medicine (M.S.W.), the NIH National Heart, Lung, and Blood Institute
(R01HL104129), and the Leducq Foundation (M.S.W.).
Disclosures: None declared.The Bcl2-associated athanogene (BAG) 3 protein is a
member of the BAG family of cochaperones found
primarily in skeletal and cardiac muscle. Within muscle
cells, BAG3 colocalizes with desmin and a-actinin at the
sarcomere Z-disk, a primary node where mechanical
stimulation is translated to signal transduction pathways
allowing the cell to respond to stress. Native BAG3 has
been implicated in apoptosis, development, cytoskeletal
organization, and autophagy, allowing cells to adaptstigative Pathology. Published by Elsevier Incto external stimuli.1 Mechanical stimulation itself
induces BAG3 expression,2e4 which may indicate its role
in the maintenance of the skeletal muscle sarcomere in
disease.. All rights reserved.
Quintana et alMyofibrillar myopathies are a heterogeneous group of
skeletal and cardiac muscle diseases caused by mutations in
eight sarcomere proteins, including BAG3.5 At least 10
mutations have been reported in BAG3, nine resulting in a
dilated cardiomyopathy.6e8 One of the most commonly
reported mutations is the P209L missense mutation, result-
ing in particularly affected cardiac phenotype, constituting a
subset of myofibrillar myopathies leading to both skeletal
muscle and cardiac complications.6,9e11 Because the P209L
mutation is found at amino acid 209, it is worth mentioning
that recent studies have found that the Bag3 Ile-Pro-Val
(IPV) motif found at amino acids 200 to 213 in Bag3
bind to the heat shock protein HSPB6.12 In patient biopsies,
the Bag3 P209L mutant leads to increased levels of HSP27
(HSPB1), CRYAB, and Bcl-2 by immunohistochemistry.10
The mutant BAG3 complex migrates farther than the wild-
type BAG3 complex in denaturing gel electrophoresis,
suggesting that the P209L mutant Bag3 interacts less with
partner proteins.10
Although little is known about the Bag3 P209L mutation,
it is distinctly not a loss-of-function mutation. Neonatal
cardiomyocytes transfected with Bag3 P209L have a greater
susceptibility to apoptosis when stressed,6 consistent with
Bag3/mice that have this same pro-apoptotic phenotype.11
Reducing BAG3 expression in zebrafish results in a severe
cardiac defect,8 likely related to its structural role facilitating
Hsc70 and CapZ, a protein linking actin filaments to the
Z-disk.2 In zebrafish, expression of Bag3 P209L induces
protein aggregates and gradually reduce the pool of BAG3.13
However, the underlying pathological mechanisms with
which the Bag3 P209L mutation causes disease have not
been identified, nor has it been previously associated with
autophagy regulation. The slowly progressive loss of cardiac
function, a key feature in BAG3 P209L patients, has similarly
not previously been identified in animal models.
To elucidate the underlying mechanisms of disease and
identify potentially targetable intermediates driving the Bag3
P209L pathology in patients, we generated cardiomyocyte-
specific (aMHC-) Bag3 P209L transgenic mice and charac-
terized their progressive cardiac phenotype in vivo over time.
Given the increasing appreciation of the role of misfolded
proteins in neurodegenerative diseases in heart failure,14 we
focused on characterizing the misfolded proteins in the Bag3
P209L Tgþ hearts, and their effects on altering mitochondrial
dynamics, effects on native BAG3 expression, and activation
of mitogen-activated protein kinase signaling paralleling that
found in the pathogenesis of neurodegenerative disease.
Unexpected proliferation of cardiac fibroblasts (lacking Bag3
P209L only found in cardiomyocytes) and activation of p38
were identified at 1 year of age, where a progressive systolic
and diastolic heart failure was identified by echocardiogra-
phy. Together, these findings point to a previously unde-
scribed therapeutic target that may have application to
mutation-induced myopathies and other common causes of
heart failure that harbor misfolded proteins, such as idio-
pathic dilated cardiomyopathy.15e181990Materials and Methods
Generation of Bag3 P209L Mouse Strain and
Experimental Design
The human Bag3 cDNA with P209L (http://www.ncbi.nlm.
nih.gov; GenBank accession number NM_004281) was
PCR amplified by the following primers: forward: XhoI-
ATG-Flag-Bag3 (50-GGCTCGAGATGGACTACAAA-
GACGATGACGACAAGGGTAGCGCCGCCACCCACT-
CG-30) and reverse: HindIII-Bag3 with stop codon
(50-CCATTGGGTCGTCGTGGCATCTTCGAAGG-30) and
cloned into the SalI and HindIII site of the aMHC promoter-
pBSIISKþ construct (gifted by Dr. Jeff Robbins, Cincinnati
Children’s Hospital, Cincinnati, OH). Positive clones were
digested with NotI, generating a 9-kb fragment, which was
injected into the pronuclei of BDF1 embryos and implanted
into pseudo-pregnant recipient females. Transgene-positive
founders were then bred onto C57BL/6 mice (Charles
River Laboratories, Inc., Wilmington, MA). Mice were
genotyped from isolated tail DNA (DNeasy Tissue
Kit; Qiagen Inc., Valencia, CA) at both weaning and
post-mortem. The Bag3 transgene was identified using stan-
dard PCR conditions (forward primer: 50-CATGCCAGA-
AACCACTCAGC-30; reverse primer: 50-GTAGACAGGT-
CCCACGTAGC-30 or forward primer/F2: 50-AGAGACG-
GTGTCAGGAAGGT-30; reverse primer/R2: 50-GAACTA-
CCCACCGTAGGGA-30). The Bag3 transgene expression
levels were approximately twofold wild-type levels. All ex-
periments were approved by the Institutional Animal Care and
Use Committee review boards at the University of North Car-
olina andwere performed in accordancewith federal guidelines.Experimental Design
All experiments described used age-matched sibling mice
(approximately 50% male/approximately 50% female).
Conscious echocardiographic analysis of cardiac function
began at 4 months of age and repeated until cardiac
dysfunction was identified (8 months) through 12 months of
age. At 12 months of life, mice were anesthetized with
isoflurane, euthanized with cervical spine dislocation, and
heart muscle was flash frozen (stored at 80C) or perfused
by gravity. After abdominal aorta transection, cardiac
perfusion was performed using a 23 g butterfly needle in the
apex, first perfusing 10 mL sterile phosphate-buffered
saline, followed by 20 mL 4% paraformaldehyde at a con-
stant rate of 1 mL/minute. Cardiac tissue was then fixed in
4% paraformaldehyde for exactly 24 hours, followed by
storage in 70% ethanol, and processed for routine paraffin-
embedded histology (5 mm thick sections) and stained with
hematoxylin and eosin, Mason’s trichrome, or fixed in 2%
paraformaldehyde and 2.5% glutaraldehyde in 0.15 mol/L
sodium phosphate buffer (pH 7.4) overnight and then
post-fixed with 1% osmium tetroxide/0.15 mol/L sodium
phosphate buffer and processed for transmission electronajp.amjpathol.org - The American Journal of Pathology
BAG3 P209L Induces p38 Signaling in Vivomicroscopy (TEM). Samples were dehydrated with
increasing concentrations of ethanol, infiltrated, and
embedded in Poly/Bed812 epoxy resin (Polysciences, Inc.,
Warrington, PA). Sections (1 mm thick) were prepared to
select representative areas by light microscopy, and sections
(70 nm ultrathin) were cut with a diamond knife. Sections
were mounted on 200 mesh copper grids and stained with
4% aqueous uranyl acetate and Reynolds’ lead citrate.
Quantitative Measure of Mitochondria by qPCR Analysis
Mitochondrial number was quantified by real-time quanti-
tative PCR (qPCR), and DNA was isolated from 50 mL
whole-heart homogenates using the DNAeasy Blood and
Tissue Kit (Qiagen; catalogue number 69506). Isolated
DNA and oligomer primers for mitochondrial cytochrome c
oxidase subunit 1 (CO1; mt-CO1), cytochrome b (Cyt-b;
mt-Cyb), and NADH dehydrogenase 1 (ND1; mt-nd1) DNA
normalized to nuclear H19 (imprinted maternally expressed
transcript, nonprotein coding) DNA were run in SYBR
Green mastermix by qPCR, including melting curves as
previously detailed.19
Mouse Echocardiography
Conscious cardiac transthoracic echocardiography was
performed on mice at monthly time points using a Visual-
Sonics Vevo 2100 ultrasound biomicroscopy system
(VisualSonics, Inc., Toronto, ON, Canada), as previously
described.20 Briefly, two-dimensional M-mode echocardi-
ography was performed in the parasternal long-axis view at
the level of the papillary muscle on loosely restrained mice
by investigators (M.T.Q., M.S.W.) blinded to mouse ge-
notype throughout the process of collection and analysis.
Anterior and posterior wall thickness was measured as
distance from epicardial to endocardial leading edges. Left
ventricular internal diameters were also measured. Left
ventricular systolic function was assessed by ejection frac-
tion, left ventrical (LV) ejection fraction % Z [(LV Vol-
ume; diastole-LV Volume; systole/LV Vol; diastole) 
100], and fractional shortening % Z [(LV end-diastolic
dimension  LV end-systolic diameter)/LV end-diastolic
diameter]  100.
Measurements represent the average of three cardiac
cycles from each mouse. To measure diastolic function,
Doppler measurement of the mitral valve flow was taken in
an apical view into the LV outflow tract under isoflurane
anesthesia, as previously described.21
Measurement of Autophagic Flux
Autophagic flux was determined in vivo from the titration of
bafilomycin A1 to optimize animal survival without eliciting
other major dysfunction, while inhibiting autophagy in the
heart, as previously described.22,23 Briefly, stock bafilomycin
A1 (number 201550A; Santa Cruz Biotechnology, Dallas,The American Journal of Pathology - ajp.amjpathol.orgTX; 3 mmol/L stock in dimethyl sulfoxide) diluted in
phosphate-buffered saline (40% dimethyl sulfoxide final)
was injected i.p. to a final concentration of 3 micromol per
kilogram in 200 mL and repeated 1 hour later. One hour after
the second injection, mice were euthanized and heart tissues
were collected for analysis by Western immunoblot for
LC3B isoforms (Sigma-Aldrich number L7543).
Histological and TEM Morphometric Analysis
Cross-Sectional Areas
Imaging of hematoxylin and eosin- and Masson’s trichromee
stained sections was obtained using Aperio Scanscope and
Aperio Imagescope software version 10.0.36.1805 (Aperio
Technologies, Inc., Vista, CA). Masson’s trichromeestained
images were taken using Aperio Imagescope (TIFF) and
analyzed using NIH ImageJ software version 1.47 (NIH,
Bethesda, MD) using Aperio exported image ruler.
Cardiomyocyte cross-sectional area was measured using
ImageJ. A minimum of 100 random cardiomyocytes was
imaged fromat least threedifferent sections fromfour biological
replicates per experimental group.
Fibrosis Analysis
Using ImageScope, positive pixel countv9 algorithm was used
onMasson’s trichromeestained histological section (hue value,
0.66; hue width, 0.1) analyzing tissue sections isolated using
the pen tool. After analysis, the calculated N positive/N total
was multiplied by 100 to give a percentage collagen content
(identifying the blue as a percentage of the tissue present).
Nuclei Counts
The ImageScope positive pixel countv9 algorithm was used
to analyze hematoxylin and eosin-stained slides for nuclei
(hue value, 0.1; hue width, 0.45; color saturation 0.3),
similarly isolated for fibrosis. The nuclei per area was
identified per mm squared.
TEM Morphometric Analysis
Cardiac sections were observed with a LEO EM910 TEM
operating at 80 kV (LEO Electron Microscopy, Thornwood,
NY) and photographed with a Gatan Orius SC1000 CCD
Digital Camera and Digital Micrograph 3.11.0 (Gatan,
Pleasanton, CA). Mitochondria cross-sectional areas were
measured using NIH ImageJ at magnifications of 5000 to
10,000. The global scale was set according to the image-
specific scale generated by Gatan camera output. An
average of 2500 mitochondria were analyzed from 30 fields
from multiple levels from three hearts per mouse cohort.
Immunofluorescence Staining of Cardiac Histological
Sections for Vimentin, AIF, FLAG (Bag3 P209L), and
TUNEL
Immunostaining was performed as described previously.24,25
Cardiac sections were stained with antibodies against the1991
Quintana et alfollowing: i) vimentin (1:100, catalogue number SC-6260;
Santa Cruz Biotechnology, Dallas, TX), or an unrelated
isotype mouse, rabbit, or goat IgG (as a negative control) at
4C overnight; ii) apoptosis-inducing factor (AIF; 1:250;
Abcam, Cambridge, MA) or an unrelated isotype mouse,
rabbit, or goat IgG (as a negative control) at 4C overnight;
iii) FLAG (DYKDDDK Tag) (1:100; Cell Signaling Tech-
nology, Danvers, MA) or an unrelated isotype mouse, rabbit,
or goat IgG (as a negative control) at 4C overnight. Slides
were then incubated with Alexa Fluor 488econjugated sec-
ondary antibodies and counterstained with DAPI (Vector
Laboratories, Burlingame, CA). Sections were then treated
with Alexa Fluor 488econjugated secondary antibodies and
counterstained with DAPI. Total positive vimentin stain cells
were identified and counted in each of the four cross-sectional
defined areas using Meta-Morph software version 7.8
(Molecular Devices). Images were taken using EVOS XL
Core cell imaging system (Life Technologies).
Apoptosis was determined in histological sections by
identifying the presence of fragmented DNA by terminal
deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) using the Roche TUNEL in situ staining
kit (Roche Molecular Biochemicals, Basel, Switzerland),
according to the manufacturer’s instructions. To detect
DNA fragmentation associated with apoptosis, we used a
fluorescence-based TUNEL followed by counterstaining
with DAPI. Histological sections were treated with a
recombinant DNase I to allow TUNEL labeling of all nuclei,
which were used as positive controls.
Western Blot Analysis
For Western blot analysis, 24- to 36-day-old hearts were
homogenized in radioimmunoprecipitation assay buffer and
loaded 10 mg/lane and blotted for using mouse anti-FLAG
M2 (Sigma number A8592, 1:1000) to detect the Flag-
tagged Bag3 P209L protein, anti-serum raised against
purified GST-BAG3 recognizing both human/mouse BAG3,
and anti-actin (Calbiochem Corp., catalogue number CP01,
Ab-1/JLA20). Western analysis of ventricular tissue was
performed on lysates generated from approximately 25 mg
tissue placed in 8 mol/L Urea Lysis Buffer (8 mol/L Urea
Sigma, catalogue number U0631, 5 mol/L NaH2PO4 Sigma,
catalogue number S3139, 1 mol/L Tris-Cl, pH 8.0) at a ratio
of 15 mL lysis buffer/mg of tissue and was homogenized at
4C (TissueLyser LT, Qiagen, catalogue number 85600)
for 2 minutes. The homogenate was centrifuged at 4C,
16,000  g for 15 minutes, and the supernatant stored at
80C. Protein concentration was determined using the
Bio-Rad DC Protein Assay Reagent Package (Bio-Rad
Laboratories, Inc., Hercules, CA, catalogue number 500-
0116). Proteins (30 to 50 mg/lane) were resolved on
NuPAGE Bis-Tris or Tris-Acetate 10- and 15-well gels.
Rabbit anti-ubiquitin (Sigma L7543, 1:500) was used to
measure changes in ubiquitination. Mouse antieNF-kB p65
(total) and rabbit antiephospho-NF-kB p65 (Ser536) were1992used to measure NF-kB signaling (Cell Signaling Tech-
nologies, catalogue number 4767, each 1:500). Rabbit anti-
LC3 (Sigma L7543, 1:500) was used to measure autophagic
flux. Rabbit anti-p38 and phospho-p38 (Cell Signaling,
9212, 9211, each 1:1000) was used to measure p38 acti-
vation. Rabbit anti-PRDX1 and anti-SSADH (Sigma
SAB2101877 and PRS4807, each 1:1000) were used to
detect periredoxin and succinic semialdehyde dehydroge-
nase. Primary antibodies were diluted in 1 Tris-buffered
saline and Tween 20 or 4% bovine serum albumin and
incubated at 4C overnight. Horseradish peroxidasee
labeled secondary antibodies against mouse (Sigma A9917,
1:10,000), goat (Sigma A4174, 1:10,000), and rabbit (Sigma
A9169, 1:5000) were used to detect the primary antibodies
diluted in 1 Tris-buffered saline and Tween 20 and incu-
bated 1 hour at room temperature. Mouse antieb-actin
(Sigma, Inc., catalogue number A2228, 1:4000) or mouse
antieglyceraldehyde-3-phosphate dehydrogenase (Sigma,
Inc., catalogue numberG8795, 1:5000) were used as a
loading control. Secondary antibody horseradish peroxidase
was detected using ECL Select (GE Healthcare, catalogue
number RPN2235) and imaged using the MultiDoc-it
Imaging System (UVP, LLC, Upland, CA).
RNA Isolation and Quantitative PCR Analysis of Gene
Expression, Mitochondrial Dynamics
Total RNAwas isolated using TRIzol reagent, according to the
manufacturer’s protocols (Life Technologies, Inc., catalogue
number 15596-026). Approximately 25 mg of cardiac ven-
tricular tissue was put into TRIzol reagent and homogenized at
4C (TissueLyser LT, Qiagen, catalogue number 85600).
Total mRNA expression was determined using a two-step
reaction. cDNA was made from total RNA using the iScript
Reverse Transcription Supermix for RT-qPCR kit (catalogue
number 170-8841, Bio-Rad), with a total volume of 20 mL per
reaction. The complete reaction mix was incubated in an
Eppendorf Cycler (Hamburg, Germany) using the following
protocol: priming 5 minutes at 25C, reverse transcription 30
minutes at 42C, room temperature inactivation 5 minutes at
85C. PCR products were amplified on a Roche Lightcycler
480II system using cDNA, Taqman Probes (Applied Bio-
sciences), and Lightcycler 480 Probe Master Mix 2X (cata-
logue number 04 707 494 001). The TaqMan probes used in
this study were Hs99999901_s1 (18S), Mm00600555_m1 (b-
MHC, Myh7), Mm01255747_g1 (ANF), Mm00435304_g1
(BNP), Mm00808218_g1 (Acta1, skeletal muscle a1-actin),
Mm01278171_m1 (mouse Bag3, spanning exons 2 to 3),
Hs00188713_m1 (human Bag3, spanning exons 1 to 2), Opa1
(Mm00453879_m1), Drp1 (Mm01342903_m1), Fis1
(Mm00481580_m1), andMfn1 (Mm00612599_m1) (Applied
Biosystems, Inc., Foster City, CA). Samples were run in
triplicate, and relative mRNA expression was determined
using 18S as an internal endogenous control. RNase-free
water, 2X Master Mix, Taqman Probe, or Roche UPL primer
and probe, and cDNA were used for each reaction.ajp.amjpathol.org - The American Journal of Pathology
BAG3 P209L Induces p38 Signaling in VivoProtein Aggregation Assay and Preamyloid Oligomer
Staining
Protein aggregation was assessed using an Enzo Proteostat
Protein Aggregation Assay (ENZ-51023, Farmingdale, NY)
in conjunction with their preformulated aggregation stan-
dards (ENZ-51039). Briefly, protein lysates were prepared
from flash-frozen apical cardiac tissues using 8 mol/L urea
lysis buffer, protein concentrations were determined by
Bradford assays, and assays were performed in 96-well,
black-walled, clear-bottom plates read on a Clariostar
microplate reader at 550-nm excitation and 600-nm emis-
sion with gain setting between 1000 and 2000. Preamyloid
oligomer staining was performed as previously described
using the A11 and MF20 antibodies.26
Nontargeted Metabolomics Determination by Gas
ChromatographyeMass Spectrometry Instrumentation
Cardiac tissue was flash frozen with liquid nitrogen cooled
in a biopress, a fraction weighed (approximately 25 to 30
mg weight), finely ground, and added to fresh 50% ace-
tylnitrile, 50% water, and 0.3% formic acid at a standard
concentration of 25 mg/475 mcl buffer, then fully homog-
enized on ice for 10 to 25 seconds and placed on dry ice/
stored at 80C. Samples were crash deprotonized by
methanol precipitation and spiked with D27-deuterated
myristic acid (D27-C14:0) as an internal standard for
retention-time locking and dried. The trimethylsilyl (TMS)-
D27-C14:0 standard retention time was set at *16.727 mi-
nutes. Reactive carbonyls were stabilized at 50C with
methoxyamine hydrochloride in dry pyridine. Metabolites
were made volatile with TMS groups using N-methyl-N-
(trimethylsilyl) trifluoroacetamide or MSTFA with catalytic
trimethylchlorosilane at 50C. Gas chromatographyemass
spectrometry methods were adopted from Roessner et al,27
Fiehn et al,28 and Kind et al,29 which used a 6890 N gas
chromatograph connected to a 5975 Inert single quadrupole
mass spectrometer (Agilent Technologies, Santa Clara, CA).
The two wall-coated, open-tubular gas chromatography
columns connected in series are both from J&W/Agilent
(part 122e5512), DB5-MS, 15 m in length, 0.25 mm in
diameter, with an 0.25-lm luminal film. Positive ions
generated with conventional electron-ionization (EI) at 70
eV are scanned broadly from 600 to 50 m/z in the detector
throughout the 45-minute cycle time. Data were acquired
and analyzed as previously described.30,31 All raw data and
transformed data included in the analysis are included in
Supplemental Tables S1 and S2, respectively.
Thioredoxin Reductase Assay
Flash-frozen cardiac tissue (approximately 20 mg) was
homogenized at a ratio of 10 mL lysis buffer/mg of tissue
according to the manufacturer’s protocols to prepare assay
homogenate (TissueLyser LT, Qiagen, catalogue numberThe American Journal of Pathology - ajp.amjpathol.org85600). Protein concentration was determined using the
Pierce 660 nm Protein Assay Reagent (Thermo Fisher
Scientific, catalogue number 22660) and assayed for thio-
redoxin reductase activity using a Thioredoxin Reductase
Assay (Sigma, catalogue number CS0170) according to the
manufacturer’s protocol. Protein (100 mg) was incubated
on a U bottom 96-well plate with DTNB containing
reaction mix in the presence or absence of a thioredoxin
reductaseespecific inhibitor and read at 412 nm using a
Clariostar microplate reader.Statistical Analysis
Prism 6 for Mac OS X (Version 6.0f, August 5, 2014) or
SigmaPlot for Windows (Version 11.0 Build 11.0.0.77) was
used to plot and statistically analyze data using a t-test
with significance defined as P < 0.05. Statistical analysis
on metabolomics data was performed as previously
described.30,31 Briefly, Metaboanalyst (v2.0) run on the
statistical package R (v2.14.0) used metabolite peak areas (as
representative of concentration).32,33 These data were first
analyzed by an unsupervised principal component analysis.
To sharpen the separation between groups, data were next
analyzed using a partial least squares discriminant analysis to
further determine which metabolites were responsible for
separating these two groups. The specific metabolites
contributing most significantly to the differences identified
by partial least squares discriminant analysis between Bag3
P209L and wild-type control group hearts were determined
using the variable importance in projection (VIP) analysis in
the Metaboanalyst environment. The metabolites that best
differentiated the groups were then individually tested using
the t-test (Microsoft Excel 2011, Seattle, WA). The VIP and
t-test significant metabolites were matched to metabolomics
pathways using the Pathway Analysis feature in Metab-
oanalyst 2.0. Heat maps of the metabolite data (individual
and grouped) were generated using the GENE E software
version 3.0.2014 (http://www.broadinstitute.org/cancer/
software/GENE-E/index.html; last accessed February 20,
2016).Results
The BAG3 P209L missense mutation in exon 3 is one of the
most recently identified causes of myofibrillar myopathy
resulting in cardiac complications.10 In contrast to other
myofibrillar myopathies, the BAG3 cardiomyopathy
manifests as hypertrophic cardiomyopathy in the first to
second decades of life.5,10 Bag3 constitutive expression is
restricted to few cell types, including skeletal muscle and
cardiomyocytes.2 However, it is induced in a subset of cells
(retinal, glial, epithelial, leukocytes) by a variety of stressors
to induce resistance.34e37 To generate a cardiac model that
paralleled human disease without the indirect effects of a
skeletal phenotype, including respiratory distress and1993
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Figure 1 Cardiac function and natural history of aMHC-Bag3 P209L transgenic mouse cardiac phenotype up to 12 months of age. A: Western blot analysis
of Bag3 P209L expression by anti-FLAG (FLAG-Bag3 P209L) demonstrating specificity and by anti-BAG3 (human and mouse) to compare relative levels of total
BAG3 in cardiac and gastrocnemius tissue from aMHC-Bag3 P209L and littermate wild-type mice. B: Mendelian ratios of offspring at the time of genotyping at
14 to 21 days post-partum. C: Kaplan-Meier survival curves of Bag3 P209L Tgþ and sibling wild-type mice. DeG: Temporal changes in fractional shortening %,
calculated as (LVEDD-LVESD)/LVEDD  100, see Table 2 (D), left ventricular end diameter; diameter (E), anterior wall thickness in diastole (AWTD) (F), and left
ventricular mass (G), corresponding to the complementary morphometrics in Table 2. H: Measured total heart weight (normalized to tibia length) at 1 year of
age. I: Analysis of diastolic function made from Doppler measures of mitral valve at 1 year of age. A t-test was used to compare genotypes at each time point.
Data are expressed as means  SEM (DeI). NZ 47 (B); NZ 68 (C); NZ 3 (DeG, baseline Bag3 P209LTgþ and 5 months Bag3 P209LTgþ); NZ 4 (DeG, 8
months Bag3 P209LTgþ); NZ 5 (DeG, baseline wild-typeBag3 P209L Tgþ and 5 months wild-typeBag3 P209L Tgþ); NZ 7 (DeG, 8 months wild-typeBag3 P209L Tgþ);
NZ 10 (DeG,12 months wild-typeBag3 P209L Tgþ and BAG3 P209LTgþ); NZ 4 (H, Bag3 P209LTgþ); NZ 7 (H, wild-typeBag3 P209L Tgþ); NZ 3 per group (I).
*P < 0.05, **P < 0.005 versus age-matched sibling wild-type mice. IB, immunoblot; LV, left ventricle; LVEDD, left ventricular end-diastolic diameter.
Quintana et allimited mobility, we generated an aMHC-driven BAG3
P209L transgenic mouse. The resulting mouse exhibited a
modest constitutive increase in total BAG3 expression
(approximately twofold wild-type levels) (Figure 1A),
localized to the heart (cardiomyocyte). Because we crossed
Bag3 P209L Tgþ with wild-type mice, we looked for evi-
dence of prenatal death by comparing the expected 50%
ratios with the observed. There was no evidence that the
Bag3 P209L Tgþ offspring were underrepresented, with
>50% Bag3 P209L Tgþ by genotyping (Figure 1B and
Table 1). The distribution of offspring with Bag3 P209L
Tgþ and sex similarly did not differ between groups
(Supplemental Figure S1 and Supplemental Table S3),
demonstrating that the Bag3 P209L Tgþ did not alter1994viability during development. Body weight from 4 months
of age through 12 months was not significantly different
between wild-type Bag3 P209L Tgþ mice, as shown in
Table 2 (row 1).
Because the Bag3 P209L Tgþ was expressed specifically
in cardiomyocytes, we focused our analysis on cardiac
function, performing conscious echocardiography over time,
starting at 4 months of age and continuing through 1 year,
along with mechanistic studies. Postnatally, we identified
only one mouse that died prematurely, which was a Bag3
P209L Tgþ mouse on day 243 (Figure 1C). Unfortunately,
we were unable to perform a necropsy to determine any
contributions of the mutation to its death, but did confirm
we had identified systolic dysfunction by echocardiographyajp.amjpathol.org - The American Journal of Pathology
Table 1 Analysis of Mendelian Ratios Breeding Bag3 P209L Tgþ with Strain-Matched Wild-typeBag3 P209L Tgþ Mice (50% Expected Tgþ)
Outcome Expected (no.) Observed (no.) Expected (%) Observed (%) 95% CI of observed %
Wild-typeBag3 P209L Tgþ 23.5 28 50 59.57 44.27e73.63
Bag3 P209L Tgþ 23.5 19 50 40.43 26.37e55.73
Total 47 47 100 100
A binomial test was performed and a one-tailed and two-tailed P was determined to be not significant (0.1215 and 0.2430, respectively). See Figure 1B for
pie chart of distribution.
BAG3 P209L Induces p38 Signaling in Vivoprior. By 8 months of age, significant systolic dysfunction
was seen, evidenced by decreases in fractional shortening
(Figure 1D) and ejection fraction (Table 2). Although Bag3
P209L Tgþ hearts demonstrated significant dilation at 8
months (Figure 1E) and had significantly increased anterior
wall thickness (Figure 1F), there was no difference in LV
mass determined by echocardiographic measurements
(Figure 1G) or measured heart weight at 12 months of age
(Figure 1H).
Of the six genes found to be mutated and leading to
myofibrillar myopathies [desmin, aB-crystallin, myotilin,
LDB3 (ZASP), FLNC, and BAG3], only 15% to 30% of
patients with these mutations present with a cardiomyopa-
thy.5 As the disease progresses, up to 60% develop car-
diomyopathies, including dilation (17%), restrictions (12%),
and/or hypertrophic (6%) cardiomyopathy.38 The first case
of a Bag3 P209L mutation reported in 2009 identified a
childhood onset with severe progressive muscle weakness
with atrophy, along with a restrictive cardiomyopathyTable 2 High-Resolution Transthoracic Echocardiography Performed o
over 1 Year
Variable
Baseline wild-
typeBag3 P209L Tgþ
control
Baseline
Bag3
P209L Tgþ
5 Months wild-
typeBag3 P209L Tgþ
control
5 Months
Bag3
P209L Tg
N 5 3 5 3
Body weight (g) 27.2  1.8 23.4  1.8 28.5  1.7 25.5 
AWTS (mm) 1.74  0.05 1.68  0.03 1.77  0.05 1.73 
LVESD (mm) 1.83  0.06 1.85  0.15 1.9  0.11 1.87 
PWTD 0.89  0.01 0.97  0.02* 0.96  0.03 1.03 
PWTS 1.45  0.09 1.40  0.06 1.47  0.05 1.43 
LV %EF 81.3  0.9 78.6  0.9 80.1  1.6 77.5 
LV Mass (mg) 121.8  5.0 124.0  16.1 127.2  11.3 129.8 
LV Vol; d (mL) 54.4  4.1 49.2  8.3 57.0  6.5 47.7 
LV Vol; s (mL) 10.2  0.9 10.7  2.1 11.4  1.6 11.0 
PWTHy (%) 63.6  10.0 44.7  5.6 53.8  3.8 39.2 
RWT; dz 0.52  0.02 0.58  0.04 0.52  0.03 0.61 
RWT; sx 1.75  0.09 1.69  0.11 1.73  0.14 1.72 
HR (bpm) 645  14 713  12 677  17 663 
Baseline echos taken at 4 months of age. Approximately 50% female and appro
means  SEM. A t-test was performed comparing Bag3 P209L Tgþ to sibling wild
*P < 0.05.
yPWTH Z [(LVPW; s  LVPW; d)*100%/LVPW; d].
zRWT; d Z LVPW; d þ LVAntW; d/LVEDDd.
xRWT; s Z LVPW; s þ LVAntW; s/LVEDDs; LVPW; d.
AWTD, anterior wall thickness in diastole; AWTS, anterior wall thickness in sy
calculated as (end Simpson’s diastolic volume e end Simpson’s systolic volume
diameter; FS, fractional shortening, calculated as (LVEDD  LVESD)/LVEDD  100;
ventricular end-systolic dimension; ND, not determined; PWTD, posterior wall th
thickness in systole; RWT; relative wall thickness; s, in systole; vol, volume.
The American Journal of Pathology - ajp.amjpathol.orgpattern.5,10 Because of the restrictive cardiomyopathy
pattern, we hypothesized that the Bag3 P209L Tgþ mice
had exhibited diastolic dysfunction, being unable to relax.
We performed Doppler analysis on the mitral valve in Bag3
P209L Tgþ mice at 12 months of age and determined an E/a
waveform ratio (Figure 1I). Wild-type mice exhibited a
dynamic relation during the cardiac cycle, exhibited an E/a
ratio of nearly 2.0, consistent with healthy human heart
function generally around 1.5 to 2.0 E/a ratio. In contrast,
the Bag3 P209L Tgþ hearts had a reduced diastolic func-
tion, with an E/a ratio of approximately 1.0 (Figure 1I).
The severity of the heart failure was limited in the Bag3
P209L Tgþ hearts, because there was no evidence of
congestive heart failure, such as fluid accumulation in the
lungs (Figure 2A). Blinded cross-sectional analysis
(M.T.Q.) of Masson’s trichromeestained histology revealed
that the Bag3 P209L Tgþ hearts exhibited a significant
increase in cardiomyocyte size (Figure 2B), with no evi-
dence of increased fibrosis, quantified by algorithmicn Conscious Bag3 P209L Tgþ and Strain-Matched Sibling Controls
þ
8 Months wild-
typeBag3 P209L Tgþ
control
8 Months
Bag3
P209L Tgþ
12 Months wild-
typeBag3 P209L Tgþ
control
12 Months
Bag3
P209L Tgþ
7 4 10 10
2.8 35.6  2.4 28.6  2.6 37.2  2.1 38.8  3.2
0.06 1.82  0.04 1.64  0.05* 1.81  0.04 1.74  0.04
0.16 1.76  0.06 2.33  0.12* 1.83  0.03 2.28  0.05*
0.02 1.06  0.02 0.99  0.04 1.06  0.02 0.99  0.04*
0.09 1.65  0.04 1.50  0.06 1.65  0.04 1.50  0.06
2.9 80.8  0.8 69.2  1.1* 80.5  0.6 64.2  1.1*
7.3 137.3  8.2 145.1  10.2 137.3  8.1 145.1  10.2
4.5 49.0  4.9 61.8  8.3 51.9  1.7 64.8  2.3*
2.5 9.3  0.9 19.0  2.6* 10.1  0.4 17.8  1.1*
6.2 55.9  4.2 52.8  9.4 59.7  4.5 33.6  2.0*
0.03 0.62  0.03 0.53  0.04 0.60  0.01 0.66  0.02*
0.16 1.98  0.09 1.35  0.06* 1.91  0.04 1.44  0.04*
2 683  9 679  20 671  12 672  10
ximately 50% male mice were assayed throughout the study. Data represent
-type controls.
stole; bpm, heart beats per minute; d, in diastole; EF%, ejection fraction
)/end Simpson’s diastolic volume * 100; ExLVD, external left ventricular
HR, heart rate; LVEDD, left ventricular end-diastolic dimension; LVESD, left
ickness in diastole; PWTH, posterior wall thickness; PWTS, posterior wall
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Figure 2 Morphometric analysis of aMHC-
Bag3 P209L transgenic hearts. A: Heart weight
and lung weights at 12 months of age. B: Cross-
sectional analysis of cardiomyocytes from Mas-
son’s trichromeestained histological sections. C:
Analysis of collagen in aMHC-Bag3 P209L and
littermate wild-type hearts by nonbias computer
logarithm analysis of collagen as a measure of
fibrosis (N Z 6 wild-typeBag3 P209L Tgþ, N Z 4
Bag3 P209L Tgþ). D: Transmission electron mi-
croscopy analysis of aMHC-Bag3 P209L and
littermate wild-type mice at 5 and 20,000
(N Z 3/group). A t-test was used to compare
genotypes at each time point. Measurements
represent means  SEM (AeC). N Z 3 per group
(AeC). ***P < 0.001. Scale bars: 0.5 mm (D, top
row); 1 mm (D, bottom row). Original magnifica-
tion: 20 (B); 10 (C).
Quintana et alanalysis of collagen (Figure 2C). Transmission electron
microscopy revealed no alterations or abnormalities in the
Bag3 P209L sarcomere structures throughout the heart
(Figure 2D). Taken together, the Bag3 P209L Tgþ hearts
were normal at birth, and progressively developed both
systolic and diastolic heart failure at 1 year of age, with no
evidence of prenatal lethality and minimal mortality
(3.7% Z 1/27).
To better understand the mechanistic cause of the
observed cardiac dysfunction, we next investigated how
alterations in autophagy, also recognized as the lysosomal
degradation pathway, may be related to the cardiac
dysfunction seen in the Bag3 P209L Tgþ hearts. The pri-
mary reason autophagy was of interest in this model was the
fact that wild-type Bag3 has recently been implicated in the
regulation of chaperone-assisted selective autophagy in
muscle.14,39 In these studies, the protein Starvin and Bag3
coordinated machinery were required for the maintenance of
the Z disk while Bag3 coordinated the connection between
HSC70, the small heat shock protein HspB8, and the
ubiquitin ligase CHIP with the autophagic ubiquitin adaptor
p62.40 Second, mutations in other myofibrillar proteins such
as aB crystallin (eg, CryAB R120G) have been shown to1996induce endoplasmic reticulum stress41 and increase auto-
phagy to enhance the removal of proteotoxic misfolded
proteins.42 We first investigated if amyloid fibrils were
present by measuring amyloid using a dye-based Proteostat
assay to measure protein aggregation. In Bag3 P209L hearts
expressing the transgenic protein at 12 months of age
(Figure 3A), no increase in protein aggregation was detected
in heart lysates compared with wild-typeBag3 P209L Tgþ mice
in vivo (Figure 3B). We next investigated if alterations in
autophagic flux were present by quantifying the amount of
LC3II levels in the heart. No significant differences were
seen between Bag3 P209L Tgþ and age-matched wild-type
hearts at 12 months of age (Figure 3C) when treated with
and without bafilomycin A1 treatment, using doses previ-
ously described to accumulate stop lysosomal degrada-
tion23,42,43 (Figure 3D). Quantitative measurement of genes
involved in the autophagic process (mRNA) was then
analyzed for evidence of altered autophagy (Figure 3E). No
differences in Atg5, Atg7, Atg12, Bnip3, LC3, or Vps34
mRNA were identified compared to wild-type hearts
(Figure 3E). Although mutations in other myofibrillar pro-
teins causing cardiomyopathy enhance autophagy, the Bag3
P209L mutation did not alter this lysosomal degradationajp.amjpathol.org - The American Journal of Pathology
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Figure 3 Analysis of protein aggregate and autophagic
flux inaMHC-Bag3 P209L transgenic hearts at 12months.A:
Immunofluorescence detection of FLAG-Bag3 P209L in
transgenic, but not wild-type, hearts. B: Colorimetric
staining of protein aggregation. C: Western blot analysis of
cardiac autophagic flux from aMHC-Bag3 P209L and litter-
mate wild-type mice at 12 months of age. D: Western blot
analysis demonstrating that bafilomycin induction is
adequate. E: Real-time quantitative RT-PCR analysis of
Atg5, Atg7, Atg12, Bnip3, LC3, and Vps34, mediating
autophagy. A t-test was used to compare genotypes at each
time point. Measurements represent means  SEM (B, C,
and E). NZ 6 per group (B and E); NZ 3 per group (C). IB,
immunoblot; IF, immunofluorescence.
BAG3 P209L Induces p38 Signaling in Vivopathway significantly. Alterations in cardiac function do not
appear to be related to changes in autophagic flux in this
model.
An essential underlying mechanism of heart failure is the
loss of myocytes by apoptosis.44,45 In tumor cell lines,
silencing of Bag3 enhances apoptosis, whereas increasing
Bag3 inhibits spontaneous or drug-induced apoptosis.37,46e53
Different mechanisms have been identified in cancer,
including Bag3’s protection of IKKg from proteasome
delivery promoting cell survival.37 We next investigated the
potential role of apoptosis in the Bag3 P209L Tgþ hearts by
measuring cardiac apoptosis by TUNEL and AIF immuno-
fluorescence (Figure 4A). TUNEL positivity was investigated
in both fibroblasts (TUNELþ, vimentinþ) and in non-
fibroblast cells (TUNELþ, vimentin negative) made up
primarily of cardiomyocytes. Significantly less apoptosis
(TUNELþ) was seen in the Bag3 P209L Tgþ fibroblasts
(Figure 4A), whereas Bag3 P209L Tgþ cardiomyocytes
(TUNELþ and vimentin negative cells) trended higher
compared to sibling wild-type controls at 1 year of age
(Figure 4B). No differences in AIF staining were seen
in between Bag3 P209L Tgþ hearts and sibling-matched
wild-type controls (Supplemental Figure S2). This led us toThe American Journal of Pathology - ajp.amjpathol.orgfurther analyze the fibroblast (Vimentinþ) characteristics his-
tologically (Figure 4B). Unexpectedly, we identified that the
Bag3 P209L Tgþ hearts exhibited more vimentinþ cells
compared to wild-type hearts (Figure 4B). Hearts were
analyzed in quadrants as outlined in Figure 4C, with quadrant 2
and quadrant 3 (Q2 and Q3) including primarily the left
ventricle and quadrant 1 and quadrant 4 (Q1 and Q4) making
up the right and upper left ventricle and septum. Blinded
quantitative analysis (C.C.Y.) of vimentin (þ) cells from
multiple animals identified a consistent and significant increase
in the left ventricle (Figure 4A), which was distinctly different
from that found in Q1 and Q4 (Supplemental Figure S3).
Identification of vimentin in parallel studies of cardiac ventri-
cles in Bag3 P209L Tgþ hearts at 12 months illustrates that
approximately fivefold more vimentin is present (Figure 4D).
Qualitatively, these vimentin (þ) cells in the Bag3 P209L Tgþ
hearts were distributed around the vasculature, which may
represent smooth muscle or fibroblast pericytes (Figure 4B).
This vascular distribution of vimentin (þ) cells was not seen in
any of the age-matched wild-type controls (Figure 4B).
Together, these findings indicate that the Bag3 P209L Tgþ
hearts do not have increases in cardiomyocyte apoptosis at 12
months of age, but have an enhanced fibroblast presence in the1997
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Figure 4 aMHC-Bag3 P209L transgenic hearts have increased left ventrical (LV) fibroblast areas in a perivenular distribution and decreased fibroblast
apoptosis. A: Costaining of TUNEL positive nonfibroblast (left) and fibroblast (vimentin positive) cells by immunohistochemistry. B: Representative confocal
immunofluorescence images of cardiac fibroblasts from histological sections of aMHC-Bag3 P209L and littermate wild-type mice at 12 months of age. Shown
are quadrant 2 and quadrant 3, tracking with the LV (quadrant 1 and quadrant 1 primarily right ventricle). C: Nonbias quantitative logarithmic analysis of
vimentin (þ) cell staining in quadrants 1 to 4. D: Western immunoblot analysis of cardiac vimentin in Bag3 P209L hearts compared to wild-type hearts at 12
months of age. A t-test was used to compare genotypes at each time point. Measurements represent means  SEM (A). NZ 12 (A, wild-typeBag3 P209L Tgþ);
N Z 6 (A, Bag3 P209L Tgþ cardiac sections). *P < 0.05 versus age-matched sibling wild-type mice. Scale barsZ 200 mm (B). IHC, immunohistochemistry;
TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling. AU, arbitrary units; IB, immunoblot; IF, immunofluorescence.
Quintana et alleft ventricle and an increase in pericytes. With the ability to
inhibit vessel formation and induce vessel dissociation,54 their
role in the heart has been attributed to their contributions to
tissue repair.55,56
Recent studies have linked the presence of pre-amyloid
oligomers to cardiac dysfunction and heart failure.1998Mutations in the cardiac myofibrillar protein CryAB,
another small heat shock protein, have been shown to
result in the accumulation of proteotoxic misfolded pro-
tein, characterized by reactivity to an amyloid recognizing
antibody.17,18,57 Interestingly, antibodies recognizing am-
yloid conformations have been shown to react similarly inajp.amjpathol.org - The American Journal of Pathology
BAG3 P209L Induces p38 Signaling in Vivomultiple causes of human heart failure.17 Subsequently,
cardiac expression of a misfold prone protein [poly-
glutamate 83 (PQ83) repeat] was compared to the cardiac
expression of a protein not prone to misfold (PQ19 repeat)
to demonstrate the proteotoxicity of these proteins in
cardiomyocytes.16 The resulting PQ83 mice progressed
rapidly into heart failure and death, whereas the PQ19
were entirely unaffected.16 The PQ83 hearts had car-
diomyocyte accumulation of the preamyloid oligomers
(PAOs), whereas the PQ19 did not, illustrating the caus-
ative role of the misfolded proteins in heart failure that are
identified as PAOs.16 This led us to hypothesize that the
Bag3 P209L Tgþ heart failure may be mediated by the
accumulation of PAO. Immunohistochemistry of PAO
(recognized by the A11 antibody) colocalizing with car-
diomyocytes (recognized by the MF20 antibody) was
performed on Bag3 P209L Tgþ heart sections (Figure 5A).
Although gross histological analysis did not reveal overt
differences in the Bag3 P029L Tgþ hearts (Figure 5B),
differences in infiltrating immune cells were detected on
higher-power evaluation (Figure 5C). When quantified by
nuclei counts using an algorithm recognizing nuclei as a
function of area, significantly more nuclei were present in
the Bag3 P029L Tgþ hearts (Figure 5D), consistent with
an increase in infiltrates, likely immune cells. Several
hypotheses have emerged concerning the cellular mecha-
nisms by which misfolded proteins trigger inflammation,
including the direct activation of the inflammasome by
misfolded proteins (eg, amyloid-b, amylin, serum amyloid
A, and prions) that could trigger downstream IL-1, caspase
activation, and heart failure.58
In neurodegenerative diseases where amyloidogenic
proteins, including PAOs, mediate proteotoxicity, abnormal
mitochondrial dynamics composed of fission and fusion
events have been reported.59,60 One of the distinctive find-
ings by TEM of the Bag3 P209L Tgþ hearts was the
apparent dysregulation of the mitochondrial sizes, briefly
illustrated in Figure 2D. We next analyzed the TEM images
in more detail, assaying sections throughout the ventricles of
the Bag3 P209L Tgþ and wild-type hearts (Figure 6). We
identified an apparent increase in mitochondria by manual
counting of TEM images (Figure 6A), but only mild
decreases in area (Figure 6B). These manual counts were
complemented by quantitative analysis of mitochondrial
genes normalized to a nuclear intron (H19) (Figure 6C).
Although mitochondrial NADH dehydrogenase 1 (ND1),
cytochrome-b (Cytb), and cytochrome-c oxidase 1 (CO1)
were increased in the Bag3 P209L hearts, significant
increases were found only in ND1, consistent with a nearly
doubling of the mitochondrial number (Figure 6C). Mito-
chondrial dynamics are regulated by a number of key
proteins encoded by mitofusins (Mfn1, Mfn2) and optic
atrophy (Opa1) to regulate mitochondrial fusion and
dystrophin-related protein 1 (Drp1) and fission 1 homolog
(Fis1) that regulate mitochondrial fission.61 We identified
that the Bag3 P209L Tgþ hearts had significant decreases inThe American Journal of Pathology - ajp.amjpathol.orgthe mitochondrial fusion Opa1 mRNA (Figure 6D) and the
mitochondrial fission Drp1 mRNA (Figure 6E). No differ-
ences in Bag3 P209L cardiac Mfn1 or Fis1 were present
compared to wild-type hearts (Figure 6, D and E). With an
increased number of smaller mitochondria, Bag3 P209L
Tgþ hearts exhibited significant alterations in Opa1 and
Drp1 involved in regulating fusion and fission, respectively.
Alterations in mitochondria led to a nontargeted metab-
olomics analysis to determine any gross metabolic changes
in the Bag3 P029L Tgþ hearts at 12 months of age
(Figure 7A). By principal components analysis, the Bag3
P029L Tgþ hearts had a distinct signature from the wild-
type hearts (Figure 7B), with 11 metabolites significantly
different by t-test (Figure 7C and Table 3). A partial least
squares discriminant analysis was also run to differentiate
the two groups (Figure 7D) by identifying unique metabo-
lites of interest, on the basis of their known relationships
indicated by their VIP score (Figure 7E). Together, these
studies found that Bag3 P209L Tgþ hearts had elevated
aspartic acid and dehydroascorbic acid and decreased
taurine, O-methylphosphate, and adenosine-5-
monophosphate (AMP). Pathway enrichment analysis of
both t-test and VIP identified metabolites found pathways
involved in D-glutamine metabolism, taurine metabolism, and
alanine, aspartate, and glutamate metabolism had the highest
impact (Supplemental Figure S4A and Supplemental Table
S4). Disease association enrichments identified that these
metabolites weremost closely associated (lowestP value) with
the heart failure metabolomics reference set, continuous
ambulatory peritoneal dialysis, and tumor-bearing mice
(Supplemental Figure S4B). These metabolites also tracked
with locations within the cell involved in mitochondria,
peroxisome, and skeletal muscle (lowest P value)
(Supplemental Figure S4C).
Recent studies have identified that Bag3 mutations in
dilated cardiomyopathy are predicted to result from loss-of-
function mutations, in which knock-down of Bag3 in a
zebrafish model recapitulated the observed heart failure.8
Because these studies implied that the loss of function,
also known as haploinsufficiency, was because of the Bag3
mutations directly, we hypothesized that the Bag3 P209L
transgene would have no effect on the endogenous wild-
type Bag3 levels. Because the Bag3 P029L Tgþ mouse
model described herein used a human Bag3 P209L trans-
gene, we next assayed the endogenous levels of (mouse)
Bag3 at 1 year of age. To our surprise, the endogenous Bag3
P209L mRNA levels (measured by qPCR of mouse Bag3
mRNA spanning exons 2 to 3) were suppressed to <20% of
wild-type heart levels (Figure 8A) with evidence of the
human Bag3 P209L present (Figure 8B). This paralleled
decreased levels of total Bag3 protein recognizing both
mouse and human P209L Bag3 (Figure 8C). There is
limited information on how Bag3 is regulated transcrip-
tionally, but involvement of the transcription factors cJun/
cFos (AP1), NF-kB, and HSF1 has been reported and may
be related to the observed findings.50,62e651999
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Figure 5 Analysis nuclei in aMHC-Bag3 P209L transgenic hearts at 12 months. A: Immunohistochemistry analysis of preamyloid oligomers (PAO; anti-A11
antibody), cardiomyocytes (anti-MF20 antibody), and IgG controls showing representative green (PAO) as a percentage of red (cardiomyocytes) in cardiac
sections. B: Gross comparison of aMHC-Bag3 P209L and littermate wild-type mice [hematoxylin and eosin (H&E) stained). C: Algorithmic analysis of nuclei
quantitated per area of cross-sectional area. D: Representative Bag3 P209L Tgþ hearts and age-matched sibling wild-type hearts with cellular infiltrates.
Representative histological section of wild-typeBag3 P209L Tgþ heart stained with H&E (D) and parallel representative cross sections of sibling Bag3 P209L Tgþ
hearts with inflammatory cell infiltrates (arrows) at 12 months of age (E). A t-test was used to compare genotypes at each time point. NZ 3 Bag3 P209L Tgþ (A);
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versus age-matched sibling wild-type mice. Original magnification: 20 (A, D, and E); 0.7 (B).
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Figure 6 aMHC-Bag3 P209L transgenic hearts
exhibit alterations in mitochondria number and
dynamics. Quantitative analysis of mitochondrial
number (A) and mitochondrial area (B) in 5000
TEM sections. C: Quantitative analysis of the mean
cytochrome c oxidase subunit 1 (CO1, aka mt-
CO1)/cytochrome b (Cyt-b, aka mt-Cyb)/NADH
dehydrogenase 1 (ND1, aka mt-nd1) normalized
to nuclear H19 (imprinted maternally expressed
transcript, non-protein coding) of aMHC-Bag3
P209L and littermate wild-type mice at 12 months
of age. Real-time quantitative RT-PCR (RT-qPCR)
analysis of genes regulating mitochondrial fusion
(mitofusin 1/Mfn1 and optic atrophy1/opa1) (D)
and mitochondrial fission (mitochondrial fission 1
protein/Fis1 and dynamic-related protein 1/Drp1)
(E). A t-test was used to compare genotypes at
each time point. Data are expressed as means 
SEM. N Z 4 (A and B, Bag3 P209L Tgþ); N Z 5
per group (C); N Z 6 per group (A and B, wild-
typeBag3 P209L Tgþ, and D and E). *P < 0.05 versus
age-matched sibling wild-type mice. nu-DNA, nu-
clear DNA; qPCR, real-time quantitative PCR.
BAG3 P209L Induces p38 Signaling in VivoThe Bag3 P209L transgenic hearts had several notable
parallels with neurodegenerative disease, including an in-
crease in pre-amyloid oligomers and a dysregulation of
mitochondrial dynamics.59,60 We hypothesized further that
the Bag3 P209L Tgþ hearts exhibited p38 activation and an
increase in ubiquitinated proteins, on the basis of recent
discoveries in models of neurodegenerative diseases. Mis-
folded protein aggregates have been reported in aged
Drosophila to activate p38 signaling66 and in neurons to
activate both the unfolded protein response and p38The American Journal of Pathology - ajp.amjpathol.orgsignaling.67,68 Analysis of phospho-p38 protein identified
that Bag3 P209L Tgþ hearts exhibited significant increases
in activated p38 compared to wild-type hearts at 1 year
(Figure 8D), with modest increases in ubiquitinated proteins
(Figure 8E). Targeted activation of p38 mitogen-activated
protein kinase in cardiomyocytes has been shown to
induce heart failure, having negative inotropic and restric-
tive diastolic effects.69 Activation of p38 in cardiomyocytes
has also been implicated in the inflammatory response,
including IL-1beinduced COX-2 expression, PGE22001
Quintana et al
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Table 3 t-Test Significant Metabolites Identified by Nontargeted
Metabolomics Analysis of Bag3 P029L Tgþ Heart versus Sibling-
Matched Wild-TypeBag3 P209L Tg Controls
t-Test significant P-value FDR
No ID 11 4.33  106 0.00037239
Aspartic acid 1 0.0001159 0.0049839
No ID 21 0.00081798 0.023449
O-Methylphosphate 0.0014924 0.032087
Dehydroascorbic acid 0.0043074 0.074088
C13 Hydrocarbon 0.0072195 0.10348
Taurine 0.010598 0.12587
Aspartic acid 2 0.011709 0.12587
No ID 14 0.021674 0.18684
No ID 10 0.021726 0.18684
Adenosine-50-monophosphate 0.045195 0.35334
Identification of metabolites indicated in Figure 7C. NZ 3 hearts per group.
FDR, false discovery rate.
BAG3 P209L Induces p38 Signaling in Vivobiosynthesis.70 Together, these findings suggest that the
Bag3 P209L drives an increase in cardiomyocyte PAOs,
which leads to p38 activation and increase protein ubiq-
uitination, as is seen in neurodegenerative diseases in vivo.Discussion
The 575 amino acid BAG3 protein is expressed predomi-
nantly in the heart and skeletal muscle and functions as a
cochaperone with members of the heat shock protein family
to facilitate multiple important cellular processes, including
the removal of misfolded and degraded proteins, apoptosis
by interacting with Bcl2, the structural integrity of the Z-
disk by binding CapZ, and chaperone-associated selective
autophagy.71 Single allele mutations in BAG3 have been
associated with adult onset hereditary dilated cardiomyop-
athy. Significant decreases in BAG3 have been identified in
end-stage failing human heart and in animal models of heart
failure secondary to myocardial infarction and pressure
overload.71 Herein, we report the first mammalian model of
a single amino acid mutation of BAG3 (P209L) in exon 3 of
Bag3 associated with the development of muscle disease
with left ventricular dysfunction and heart failure first re-
ported in 2009.10 We identified previously unreported un-
derlying mechanisms, including altered mitochondrial
dynamics (increased fragmented mitochondria), the pres-
ence of pre-amyloid oligomers, the development of wild-
type BAG3 haploinsufficiency, and activation of p38
signaling, paralleling the emerging pathogenesis in otherFigure 7 Nontargeted metabolomics analysis of aMHC-Bag3 P209L transgen
identified in aMHC-Bag3 P209L and littermate wild-type hearts at 12 months
littermate wild-type hearts. C: t-Test analysis of metabolites, including significa
discovery rate (FDR) estimate. D: Partial least squares discriminant analysis (PL
The variable influence on the projection (VIP) parameter to select variables
metabolomics profiles in a PLS-DA model. Statistical analyses were performed as
inaccurate because of imputing a non-zero value resulting from the metabolite
(AeE). WT, wild-type.
The American Journal of Pathology - ajp.amjpathol.orgdiseases of misfolded proteins, such as Alzheimer and
Huntington diseases.
Many of the findings in the present study may be related
to domain P209L mutation, as the domain is linked to the
cell’s general ability to clear misfolded proteins. BAG3 has
five domains: i) the WW domain (with two tryptophan
motifs Z WW) (amino acids 21 to 55); ii) the IPV motif 1
(amino acids 87 to 101); iii) the IPV motif 2 (amino acids
200 to 213, where P209L is located); iv) the PXXP motif
(amino acids 302 to 412); and v) the BAG motif (amino
acids 420 to 499). Each of these domains binds specific
proteins, each with distinct cellular processes. In the N-
terminal end, the WW domain is involved in the induction
of autophagy, IPV motifs (1 and 2) bind HSPB8 (and to a
lesser extent, HSPB6), the Bcl2 binds the region around
amino acid 440, and HSC70, HSP70, and CapZ bind the c-
terminal BAG domain.12,71,72 Because the P209L mutation
affects the IPV motif (amino acids 200 to 213), our findings
that the Bag3 P209L hearts did not have altered autophagy
(Figure 3) or apoptosis (Figure 4) mediated by the WW
(amino acids 21 to 55) and Bcl2 binding region (amino
acids 440), respectively, were not surprising because they
are not related to this region. Similarly, a recent report
identified that Bag3 P209L was as effective as wild-type
BAG3 in enhancing LC3 lipidation and maintaining auto-
phagic flux.73 Similarly, the lack of any alterations in the
Bag3 P209L Tgþ heart sarcomeres (Figure 2D) is also
consistent with the recent finding that the Bag3 P209L is
able to rescue the myofibrillar disintegration found when
Bag3 is knocked down in zebrafish models,13 demonstrating
that the mutation does not have dominant negative activity
and maintains structural integrity. More important, the IPV
domains (where P209L is located) associates with critical
HSPB proteins found necessary to degrade the Huntington
diseaseecausing Htt43Q mutation, caused by its misfolding
(ie, PAO) and proteotoxicity.72 Taken together, these find-
ings implicate the Bag3 P209L mutation in producing a
protein more prone to forming PAOs, or by altering the
cells’ ability to clear PAOs, or possibly both. Either way, the
altered physiology leading to heart failure identified in the
current study is mechanistically consistent with a proteo-
toxic mechanism in vivo.
Although the formation of pre-amyloid oligomers
(Figure 5A) in the aMHC-Bag3 P209L parallel those seen
in other small heat shock protein mutations, notably the
CryAB R120G, many differences exist in the cardiac phe-
notypes that these mutant and native proteins have in vivo.
At 12 months, the Bag3 P029L Tgþ heart does not have anyic hearts at 12 months of age. A: Heat map representation of metabolites
of age. B: Principal components (PC) analysis of aMHC-Bag3 P209L and
nt metabolites (above horizontal line), listed below with P-value and false
S-DA) score plot demonstrating significant separation between groups. E:
that have the most significant contribution in discriminating between
described in Materials and Methods. Double asterisks denote fold-change
not being detected in one group. N Z 3 biological replicates per group
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Figure 8 aMHC-Bag3 P209L down-regulates
wild-type BAG3 and activates P38 at 12 months
of age. Cardiac expression of endogenous mouse
Bag3 (A) and human Bag3 (B) mRNA expression
analysis by real-time quantitative RT-PCR. Western
blot analysis of total (mouse and human) Bag3
protein (C), phospho-p38/p38 (D), and ubiquiti-
nated proteins from aMHC-BAG3 P209L and litter-
mate wild-type mice (E) at 12 months of age. A
t-test was used to compare genotypes at each
time point. Measurements represent means  SEM
(AeE). NZ 4 (A, wild-typeBag3 P209L Tgþ); NZ 5 (A
and B, Bag3 P209L Tgþ); NZ 3 per group (C and
D); NZ 6 per group (B, wild-typeBag3 P209L Tgþ, and
E). *P< 0.05 versus age-matched sibling wild-type
mice. IB, immunoblot; ND, not detected.
Quintana et alincrease in fibrosis, relatively mild heart failure with mini-
mal death (only one recorded), and no classic fibril depo-
sition by TEM. In contrast, the aMHC-CryAB R120G have
100% mortality by early adulthood, considerable fibril
deposition, and impaired myofibril alignment.74 These dif-
ferences may have only to do with the amount of protein
present, secondary to its solubility and relationship to
interacting proteins they chaperone, because the native
small heat shock proteins Bag3 and CryAB have consider-
ably different roles in the adult heart. This issue with the
concentration of the mutant protein is significant, as recent
studies overexpressing the Bag3 P209L mutant protein in
cells result in dramatic increases in aggregated protein in
cell culture,75 in contrast to the present study in vivo having
only onefold to twofold increase in Bag3 P209L and a
slower clinical course as seen in the human disease. Recent
studies have found that Bag3 knockdown in adult zebrafish2004results in myofibrillar disintegration without forming protein
aggregates,13 whereas CryAB/ (and CryAB/HSPB2 dou-
ble knockout) mice do not have any ultrastructural abnor-
malities.76 The ability of the Bag3 P209L mutant protein
to rescue the BAG3 knockdown myofibillar disarray in-
dicates that its structural functions in the sarcomere are
still intact.13
The importance of maintaining BAG3 levels is highlighted
by the Bag3 knockdown studies in zebrafish, making the
transcriptional down-regulation of wild-type BAG3 a critical
finding in the present study (Figure 8A). How BAG3 is
transcriptionally regulated in the cardiomyocyte is unknown,
but multiple studies have identified that Jun proteins (c-Jun,
JunB, and JunD), which form AP-1 homodimers (Jun/Jun) or
heterodimers with Fos family members, ATF/CREB family
members, or JDP family members regulate BAG3 expression
in noncardiac cells.77 In cancer cells, c-Jun can be found toajp.amjpathol.org - The American Journal of Pathology
BAG3 P209L Induces p38 Signaling in Vivointeract with the BAG3 promoter, with less c-Jun occupancy
driving a suppression of BAG3.77
Misfolded tau proteins caused by truncation mutations have
been linked to the activation of mitogen-activated protein
kinase signaling.78 The p38 activation in Alzheimer disease
animalmodels (ie, Ab and tau toxicities) can be attenuatedwith
vitamin E79 and by medications that are used to successfully
reduce loss of memory impairment in Alzheimer disease
(Donepezil, an inhibitor of acetylcholinesterase, attenuates
amyloid-beinduced iNOS, cyclooxygenase-2, and the phos-
phorylation of p38 as well as NF-kB80). Taken together, these
studies illustrate the functional role of PAO-prone amyloid-b
and tau proteins in activating inflammation via p38 activation,
which is a therapeutic target to attenuate disease progression.
Similarly, Bag3 Tgþ hearts have both an increase in inflam-
matory infiltrates (Figure 5, CeE) and trending increases in
NF-kB activity (increased phospho-p65/p65 by Western blot)
at 12 months of age (Supplemental Figure S5).
These finding have broader implications in treating PAO-
mediated cardiac diseases, such as the Bag3 P029L muta-
tion, which currently have no therapies available beyond
traditional RAAS-targeted heart failure therapies. Similar to
the link between misfolded proteins and p38 activation in
the brain,81 the cardiac literature suggests a parallel role of
p38 in mediating heart failure and may be partially
responsible for the cardiac phenotype of the current study.
Targeted activation of cardiomyocyte p38 potently induces
cardiac hypertrophy and heart failure in vivo.69,82,83 In the
current study, a clear progressive heart failure ensues in the
Bag3 P029L Tgþ mice by 8 months of age (Figure 1, DeI),
along with cardiac hypertrophy (Figure 2B). Also like
the amyloid-b and tau proteineinduced p38 mediatede
inflammation, preliminary evidence of inflammation was
seen in the 12-month Bag3 P029L Tgþ hearts (Figure 5, B
and C).70 Evidence is accumulating that p38 inhibitors are
effective in protecting in cardiac ischemia, arrhythmias,
myocardial contractile dysfunction, myocardial infarction,
LV remodeling, atherosclerosis, and endothelial cell
dysfunction in both preclinical models and in human clinical
trials (eg, losmapimod/NCT02145468 in phase 3 for acute
MI and BMS-582949/NCT00570752 in phase 1 trials for
atherosclerosis) with potential benefit identified in patients
with early and late atherosclerosis.84 To our knowledge, p38
inhibitors have not been reported in hereditary myopathies
to date, but their use may provide a therapy that has shown
promise in other cardiac diseases, for which a specific
mechanistically rationale therapy is currently unavailable.Acknowledgments
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